CONCENTRATIONS (Details Narrative) - USD ($) |
3 Months Ended | 9 Months Ended | |||
|---|---|---|---|---|---|
Sep. 30, 2026 |
Sep. 30, 2025 |
Sep. 30, 2026 |
Sep. 30, 2025 |
Dec. 31, 2025 |
|
| Accounts Receivable [Member] | One Customers [Member] | Customer Concentration Risk [Member] | |||||
| Concentration risk | 100.00% | ||||
| Accounts Receivable [Member] | Two Customers [Member] | Customer Concentration Risk [Member] | |||||
| Accounts receivable, net | $ 253,459 | ||||
| Concentration risk | 100.00% | 100.00% | |||
| Sales Revenue [Member] | One Customers [Member] | Product Concentration Risk [Member] | |||||
| Concentration risk | 100.00% | 100.00% | 99.00% | 99.00% | |
| Sales Revenue [Member] | Two Customers [Member] | Product Concentration Risk [Member] | |||||
| Concentration risk | 100.00% | 99.00% | 99.00% | ||
| X | ||||||||||
- Definition Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition For an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|